Related Experiment Video

Updated: Jul 6, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

DNA repair deficiency as a therapeutic target in cancer

Sarah A Martin1, Christopher J Lord, Alan Ashworth

  • 1The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK.

Current Opinion in Genetics & Development
|March 18, 2008
PubMed

Insights

Targeting DNA repair deficiencies in cancer cells offers a novel therapeutic strategy. Poly(ADP-ribose) polymerase (PARP) inhibitors selectively target tumors with homologous recombination defects, particularly those with BRCA1/2 mutations, showcasing synthetic lethal approaches in cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer cells often have inherent deficiencies in DNA damage signaling and repair pathways.
  • These deficiencies contribute to cancer development and offer unique therapeutic vulnerabilities.
  • DNA repair inhibition is an established strategy to enhance cytotoxic cancer therapies.

Purpose of the Study:

  • To explore the potential of targeting DNA repair deficiencies in cancer therapy.
  • To highlight the synthetic lethal approach using poly(ADP-ribose) polymerase (PARP) inhibitors.
  • To discuss the development of novel cancer treatments based on DNA repair mechanisms.

Main Methods:

  • Review of existing literature on DNA repair inhibitors in cancer therapy.
  • Focus on poly(ADP-ribose) polymerase (PARP) inhibitors and their mechanism of action.
  • Analysis of synthetic lethality in tumor cells with specific DNA repair defects.

Main Results:

  • Poly(ADP-ribose) polymerase (PARP) inhibitors demonstrate high selectivity for tumor cells lacking homologous recombination repair.
  • This selectivity is particularly pronounced in cancers with BRCA1 or BRCA2 mutations.
  • The study suggests that other DNA repair pathways can also be targeted similarly.

Conclusions:

  • Understanding DNA repair pathways is crucial for developing innovative cancer treatments.
  • Synthetic lethal strategies targeting DNA repair offer promising avenues for selective cancer therapy.
  • Targeting tumor-specific DNA repair defects, like those addressed by PARP inhibitors, represents a significant advancement in oncology.

More Related Videos

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter06:59

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter

Published on: March 31, 2022

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...